FDA Investigator Kevin T Nguyen
Kevin T Nguyen has conducted inspections on 16 sites in 2 countries as of 06 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
16
Last Inspection Date:
06 May 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
China
FDA Investigators that have inspected at least one site in common with Kevin T Nguyen:
Adam R Cooke,
Ademola O Daramola,
Angela E Glenn,
Angela Mock,
Anh M Lac,
Aqualia L Nelson,
Ariel Cruz Figueroa,
Benjamin E Bowen,
Blondell W Johnson,
Bonita S Chester,
Brandon C Heitmeier,
CDR Ileana Barreto Pettit,
Christopher D Rush,
Daniel J Lahar,
Darla J Christopher,
David M Beltran,
Denise Connelly,
Dr. Jason R Caballero,
Ellen J Tave,
Gamal A Norton,
Gretchen M Laws,
Harshal J Desai,
Hung V Le,
Jawaid Hamid,
Jeffrey R Wooley,
Jennifer Lalama,
Jennifer M Menendez,
Jeremy L Stukes,
Joanne E King,
Jodi M Gatica,
Johann M Fitch,
Johnetta F Walters,
Jose Martinez, Jr,
Kari M Johansen,
Kari M Laynor,
Kathleen Chmura Shaffer,
Kevin P Regan,
L Grant,
Lareese K Thomas,
Latorie S Jones,
Lisa R Jennings,
Lisa R Whitt,
Lorie S Hannappel,
Lourdes R Genera,
LT Richard A Lyght,
Maotang Zhou, PhD,
Margaret M Annes,
Marie F Morin,
Massoud Motamed,
Nicole E Knowlton,
Patrick D Stone, MS,
Patty P Kaewussdangkul,
Pauline N Logan,
Philip M Steele, PhD,
Pitman,
Rachel A Gomez,
Rebecca Rodriguez,
Robert C Coleman,
Ronald Ifraimov,
Ronda Rloyd Jones,
Roy R Rinc,
Sarah E Mcmullen,
Scott T Ballard,
Sha'tina R Alridge,
Shanna N Purdy,
Shelby N Turner,
Sherrie L Krolczyk,
Sonia R Peterson,
Stephen D Brown,
Stephen L Beekman,
Steven D Dittert,
Tamera H Hunt,
Timothy H Vo,
Tomika L Crafter,
Tricia S Martinez,
Trina K Vick,
Uttaniti Limchumroon (Tom)
Kevin T Nguyen's Documents
Publish Date | Document Type | Title |
---|---|---|
February, 2023 | EIR | USpharma Ltd - EIR, 2023-02-16 |
June, 2023 | FDA 483 | Fujian Genohope Biotech Ltd - Form 483, 2023-06-02 |
May, 2024 | FDA 483 | Bonafide Innovations LLC - Form 483, 2024-05-06 |
August, 2023 | FDA 483 | Carrollclean, LLC - Form 483, 2023-08-31 |
October, 2023 | FDA 483 | Mary Kay Inc. - Form 483, 2023-10-27 |
December, 2022 | FDA 483 | Matheson Tri-Gas, Inc. - Form 483, 2022-12-09 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more